Is a 300,000 IU oral dose of Devit‑3 (vitamin D3) appropriate to give monthly to a 90‑kg adult?

A 300,000 IU monthly oral dose of vitamin D3 is NOT appropriate for routine supplementation in a 90-kg adult

This dosing regimen significantly exceeds evidence-based guidelines and carries unnecessary risks without proven long-term benefits. While high-dose bolus therapy can rapidly correct deficiency, monthly administration of 300,000 IU lacks support from current clinical practice guidelines and may increase the risk of adverse effects including hypercalcemia.

Why This Dose Is Problematic

Guideline Recommendations Favor Daily Dosing

The 2024 Endocrine Society guidelines recommend empiric daily supplementation rather than high-dose intermittent therapy 1. For adults:

• Ages 19-50: 600 IU daily (1,500-2,000 IU daily to maintain 25(OH)D >30 ng/mL)
• Ages 50-70: 600 IU daily
• Ages ≥75: Empiric supplementation recommended for mortality reduction (trials used ~900 IU daily average)

The 2011 Endocrine Society guidelines specifically state: "For empiric supplementation, daily, lower-dose vitamin D is preferred over nondaily, higher doses" 1.

Treatment vs. Maintenance Distinction

The 2011 guidelines distinguish between correcting deficiency versus maintaining sufficiency [@2-5@]:

For treating documented deficiency:

• 50,000 IU weekly for 8 weeks (total 400,000 IU over 2 months)
• Followed by maintenance of 1,500-2,000 IU daily

For obese patients (relevant to 90-kg individual if BMI elevated):

• 2-3 times higher doses may be needed (6,000-10,000 IU daily for treatment)
• Maintenance: 3,000-6,000 IU daily [@2-5@]

Evidence on 300,000 IU Bolus Dosing

Research shows that single 300,000 IU doses raise 25(OH)D levels effectively but effects wane rapidly [@7-11@]:

• One study found 300,000 IU raised levels adequately at 1 month but failed to maintain adequate responses after 60-90 days 2
• Another showed levels peaked at 3 months (81 nmol/L) but dropped to 69 nmol/L by 6 months 3
• Only 50% of patients achieved normal levels with one or two 300,000 IU doses 4

Critical safety concern: Two patients developed mild hypercalcemia (2.69 mmol/L) at 3 months after a single 300,000 IU dose 3. Monthly administration would compound this risk.

The Monthly Frequency Problem

No guideline or high-quality study supports 300,000 IU monthly (equivalent to 10,000 IU daily). This exceeds:

• The tolerable upper limit of 4,000 IU daily for routine use without medical supervision [@2-5@]
• The 10,000 IU daily maximum suggested only for correcting deficiency under monitoring [@2-5@]

One systematic review concluded that vitamin D3 doses ≥300,000 IU are effective for up to 3 months, not 1 month 5. Monthly dosing would result in cumulative excess.

Recommended Approach Instead

If Vitamin D Status Unknown:

Start with daily supplementation without testing (per 2024 guidelines) 1:

• 2,000 IU daily for general adults (well-supported by recent evidence [@14-15@])
• 3,000-6,000 IU daily if obese (BMI >30) or on medications affecting vitamin D metabolism [@2-5@]

If Documented Deficiency (25(OH)D <20 ng/mL):

Use the evidence-based loading regimen [@2-5@]:

1. 50,000 IU weekly for 8 weeks (oral vitamin D2 or D3)
2. Then switch to 1,500-2,000 IU daily for maintenance
3. For 90-kg patient with obesity: Consider 2-3× higher doses (6,000-10,000 IU daily for loading, 3,000-6,000 IU daily maintenance)

If Considering High-Dose Bolus Therapy:

Only use if adherence to daily dosing is impossible [@8,10@]:

• 300,000 IU every 3 months (not monthly) as a compromise
• Monitor calcium levels at 3 months to detect hypercalcemia
• Recognize this is less ideal than daily dosing per guidelines

Key Pitfalls to Avoid

1. Don't confuse treatment with maintenance: 300,000 IU may correct deficiency acutely but shouldn't be repeated monthly
2. Don't ignore body weight/obesity: A 90-kg patient may need higher doses if obese, but through daily dosing escalation, not mega-dose boluses
3. Don't skip calcium monitoring: High-dose regimens increase hypercalcemia risk, especially with concurrent calcium supplementation 3
4. Don't assume "more is better": Large RCTs show no fall prevention benefit from high doses in vitamin D-sufficient populations 6

Bottom Line

For a 90-kg adult, prescribe 2,000-4,000 IU daily (higher end if obese) rather than 300,000 IU monthly [@1,14,15@]. If deficiency requires rapid correction, use 50,000 IU weekly for 8 weeks then switch to daily maintenance [@2-5@]. The monthly 300,000 IU regimen lacks guideline support, provides no proven advantage over appropriate daily dosing, and increases toxicity risk.